This article in the Wall Street Journal describes Myriad Genetics' consumer-targeted ad campaign for the BRCA1 and BRCA2 tests and the ensuing debate about "who really needs the test and whether it will induce low-risk women to take drastic measures to prevent the disease," the story says. "That can mean more frequent screenings and taking certain preventive drugs, but also can include prophylactic surgical removal of a woman's breasts or ovaries." (Bet they don't mention that in the ads.)
And Speaking of Lack of Consumer Education...
Sep 11, 2007
What's Popular?